The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion

International Dairy Journal

Volumn 22, Issue 2, 2012, Pages 141-146

  Hickey, Rita M ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-ADHESIVE; BACTERIOLYTIC ENZYME; DISPLAY STRUCTURAL HOMOLOGY; DOMESTIC ANIMALS; EPITHELIAL CELL SURFACE; FREE STATE; FUNCTIONAL FOODS; HOST CELLS; HUMAN MILK; HUMAN MILK OLIGOSACCHARIDES; SOLUBLE RECEPTOR; TECHNIQUES USED;

ANIMALS; CARBOHYDRATES; CELL MEMBRANES; OLIGOSACCHARIDES; PATHOGENS; SACCHARIFICATION;

ADHESION;

ANIMALIA;

EID: 83055184171     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2011.09.012     Document Type: Review

References (80)

1. Andersson B., Dahmen J., Frejd T., Leffler H., Magnusson G., Noori G., et al. Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells. Journal of Experimental Medicine 1983, 158:559-570.
2. Andersson B., Porras O., Hanson L.A., Lagergard T., Svanborg-Eden C. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. Journal of Infectious Diseases 1986, 153:232-237.
3. Boat T.F., Davis J., Stern R.C., Cheng P.W. Effect of blood group determinants on binding of human salivary mucous glycoproteins to influenza virus. Biochimica et Biophysica Acta 1978, 540:127-133.
4. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. Journal of Nutrition 2006, 136:2127-2130.
5. Boehm G., Stahl B. Oligosaccharides from milk. Journal of Nutrition 2007, 137:847S-849S.
6. Brassart D., Woltz A., Golliard M., Neeser J.R. In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuc alpha 1-2Gal beta-bearing complex carbohydrates. Infection and Immunity 1991, 59:1605-1613.
7. Brück W.M., Kelleher S.L., Gibson G.R., Graverholt G., Lonnerdal B.L. The effects of alpha-lactalbumin and glycomacropeptide on the association of Caco-2 cells by enteropathogenic Escherichia coli, Salmonella typhimurium and Shigella flexner. FEMS Microbiology Letters 2006, 259:158-162.
8. Burford-Mason A.P., Weber J.C., Willoughby J.M. Oral carriage of Candida albicans, ABO blood group and secretor status in healthy subjects. Journal of Medical and Veterinary Mycology 1988, 26:49-56.
9. Cervantes L.E., Newburg D.S., Ruiz-Palacios G.M. α1-2 Fucosylated chains (H-2 and Lewis b) are the main human milk receptor analogs for Campylobacter (abstract). Pediatric Research 1995, 37:171A.
10. Coppa G.V., Bruni S., Zampini L., Galeazzi T., Gabrielli O. Oligosaccharides of human milk inhibit the adhesion of Listeria monocytogenes to Caco-2 cells. Italian Journal of Pediatrics 2003, 29:61-68.
11. Coppa G.V., Gabrielli O., Giorgi P., Catassi C., Montanari M.P., Varaldo P.E., et al. Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet 1990, 335:569-571.
12. Coppa G.V., Zampini L., Galeazzi T., Facinelli B., Ferrante L., Capretti R., et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatric Research 2006, 59:377-382.
13. Davis D.T., Holt C., Christie W.W. The composition of milk. Biochemistry of lactation 1983, 71-117. Elsevier Science Publishers, New York, NY, USA. T.B. Mepham (Ed.).
14. Espinosa R.M., Taméz M., Prieto P. Efforts to emulate human milk oligosaccharides. British Journal of Nutrition 2007, 98(Suppl. 1):S74-S79.
15. Fanaro S., Boehm G., Garssen J., Knol J., Mosca F., Stahl B., et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatrica Supplement 2005, 94:22-26.
16. Glass R.I., Holmgren J., Haley C.E., Khan M.R., Svennerholm A.M., Stoll B.J., et al. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. American Journal of Epidemiology 1985, 121:791-796.
17. Gopal P.K., Gill H.S. Oligosaccharides and glycoconjugates in bovine milk and colostrum. British Journal of Nutrition 2000, 84(Suppl. 1):S69-S74.
18. Hakkarainen J., Toivanen M., Leinonen A., Frangsmyr L., Stromberg N., Lapinjoki S., et al. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro. Journal of Nutrition 2005, 135:2445-2448.
19. Hickey R.M. Harnessing milk oligosaccharides for nutraceutical applications. Dairy derived ingredients. Food and nutraceutical uses 2009, 308-343. Woodhead Publishing, London, UK. M. Corredig (Ed.).
20. Hong P., Ninonuevo M.R., Lee B., Lebrilla C., Bode L. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN). British Journal of Nutrition 2009, 101:482-486.
21. Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. Journal of Virology 2005, 79:6714-6722.
22. Huang P.T., Farkas S., Marionneau W., Zhong N., Ruvoen-Clouet A.L., Morrow M., et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. Journal of Infectious Diseases 2003, 188:19-31.
23. Hueso P., Martín-Sosa S., Martín M.J. Role of milk carbohydrates in preventing bacterial adhesion. Handbook of carbohydrate engineering 2005, 141-175. Taylor and Francis, Chichester, UK. K.J. Yarema (Ed.).
24. Hurd E.A., Domino S.E. Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infection and Immunity 2004, 72:4279-4281.
25. Hutson A.M., Atmar R.L., Graham D.Y., Estes M.K. Norwalk virus infection and disease is associated with ABO histo-blood group type. Journal of Infectious Diseases 2002, 185:1335-1337.
26. Ikehara Y., Nishihara S., Yasutomi H., Kitamura T., Matsuo K., Shimizu N., et al. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiology, Biomarkers and Prevention 2001, 10:971-977.
27. Jiang X., Huang P., Zhong W., Tan M., Farkas T., Morrow A.L., et al. Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. Journal of Infectious Diseases 2004, 190:1850-1859.
28. Kawakami H. Biological significance of sialic acid-containing substances in milk and their application. Agricultural and Biological Chemistry 1997, 1:193-208.
29. van Kooyk Y., Geijtenbeek T.B. DC-SIGN: escape mechanism for pathogens. Nature Reviews in Immunology 2003, 3:697-709.
30. Kunz C., Rudloff S. Biological functions of oligosaccharides in human milk. Acta Paediatrica 1993, 82:903-912.
31. Kunz C., Rudloff S. Health promoting aspects of milk oligosaccharides. International Dairy Journal 2006, 16:1341-1346.
32. Kunz C., Rudloff S. Potential anti-inflammatory and anti-infectious effects of human milk oligosaccharides. Advances in Experimental Medicine and Biology 2008, 606:455-465.
33. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annual Reviews in Nutrition 2000, 20:699-722.
34. Kunz C., Rudloff S., Schad W., Braun D. Lactose-derived oligosaccharides in the milk of elephants: comparison with human milk. British Journal of Nutrition 1999, 82:391-399.
35. Lamey P.J., Darwazeh A.M.G., Muirhead J., Rennie J.S., Samaranayake L.P., MacFarlane T.W. Chronic hyperplastic candidosis and secretor status. Journal of Oral Pathology and Medicine 1991, 20:64-67.
36. Lane J.A., Mehra R.K., Carrington S.D., Hickey R.M. The food glycome: a source of protection against pathogen colonization in the gastrointestinal tract. International Journal of Food Microbiology 2010, 142:1-13.
37. Lesman-Movshovich E., Gilboa-Garber N. Pseudomonas aeruginosa lectin PA-IIL as a powerful probe for human and bovine milk analysis. Journal of Dairy Science 2003, 86:2276-2282.
38. Lesman-Movshovich E., Lerrer B., Gilboa-Garber N. Blocking of Pseudomonas aeruginosa lectins by human milk glycans. Canadian Journal of Microbiology 2003, 49:230-235.
39. Lin J.S., Huang J.H., Hung L.Y., Wu S.Y., Wu-Hsieh B.A. Distinct roles of complement receptor 3, Dectin-1, and sialic acids in murine macrophage interaction with Histoplasma yeast. Journal of Leukocyte Biology 2010, 88:95-106.
40. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., et al. Human susceptibility and resistance to Norwalk virus infection. Nature Medicine 2003, 9:548-553.
41. Liukkonen J., Haataja S., Tikkanen K., Kelm S., Finne J. Identification of N-acetylneuraminyl alpha 2-3 poly-N-acetyllactosamine glycans as the receptors of sialic acid-binding Streptococcus suis strains. Journal of Biological Chemistry 1992, 267:21105-21111.
42. Marionneau S., Ruvoen N., Le Moullac-Vaidye B., Clement M., Cailleau-Thomas A., Ruiz-Palacois G., et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002, 122:1967-1977.
43. Martín-Sosa S., Martín M.J., Hueso P. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. Journal of Nutrition 2002, 132:3067-3072.
44. Matrosovich M., Klenk H.D. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Reviews in Medical Virology 2003, 13:85-97.
45. Matrosovich M.N., Gambaryan A.S., Tuzikov A.B., Byramova N.E., Mochalova L.V., Golbraikh A.A., et al. Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology 1993, 196:111-121.
46. Mehra R., Kelly P. Milk oligosaccharides: structural and technological aspects. International Dairy Journal 2006, 16:1334-1340.
47. Mendes-Giannini M.J.S., Taylor M.L., Bouchara J.B., Burgerg E., Calich V.L.G., Escalante E.D., et al. Pathogenesis II: fungal responses to host responses: interaction of host cells with fungi. Medical Mycology 2000, 38:113-123.
48. Morrow A.L., Ruiz-Palacios G.M., Altaye M., Guerrero M.L., Meinzen-Derr J.K., Farkas T., et al. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. Advances in Experimental Medicine and Biology 2004, 554:443-446.
49. Morrow A.L., Ruiz-Palacios G.M., Altaye M., Jiang X., Guerrero M.L., Meinzen-Derr J.K., et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. Journal of Pediatrics 2004, 145:297-303.
50. Morrow A.L., Ruiz-Palacios G.M., Jiang X., Newburg D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. Journal of Nutrition 2005, 135:1304-1307.
51. Mysore J.V., Wigginton T., Simon P.M., Zopf D., Heman-Ackah L.M., Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999, 117:1316-1325.
52. Naarding M.A., Dirac A.M., Ludwig I.S., Speijer D., Lindquist S., Vestman E., et al. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells. Antimicrobial Agents and Chemotherapy 2006, 50:3367-3374.
53. Naarding M.A., Ludwig I.S., Groot F., Berkhout B., Geijtenbeek T.B., Pollakis G., et al. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. Journal of Clinical Investigation 2005, 115:3256-3264.
54. Neeser J.R., Golliard M., Woltz A., Rouvet M., Dillmann M.L., Guggenheim B. In vitro modulation of oral bacterial adhesion to saliva-coated hydroxyapatite beads by milk casein derivatives. Oral Microbiology and Immunology 1994, 9:193-201.
55. Newburg D.S. Are all human milks created equal? Variation in human milk oligosaccharides. Journal of Pediatric Gastroenterology and Nutrition 2000, 30:131-133.
56. Newburg D.S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. Journal of Animal Science 2009, 87:26-34.
57. Newburg D.S., Ashkenazi S., Cleary T.G. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3. Journal of Infectious Diseases 1992, 166:832-836.
58. Newburg D.S., Chaturvedi P., Lopez E.L., Devoto S., Fayad A., Cleary T.G. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. Journal of Infectious Diseases 1993, 168:476-479.
59. Newburg D.S., Peterson J.A., Ruiz-Palacios G.M., Matson D.O., Morrow A.L., Shults J., et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998, 351:1160-1164.
60. Newburg D.S., Ruiz-Palacios G.M., Altaye M., Chaturvedi P., Meinzen-Derr J., Guerrero M.L., et al. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 2004, 14:253-263.
61. Newburg D.S., Ruiz-Palacios G.M., Morrow A.L. Human milk glycans protect infants against enteric pathogens. Annual Reviews in Nutrition 2005, 25:37-58.
62. Perret S., Sabin C., Dumon C., Pokorná M., Gautier C., Galanina O., et al. Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa. Biochemical Journal 2005, 389:325-332.
63. Pieters R.J. Intervention with bacterial adhesion by multivalent carbohydrates. Medicinal Research Reviews 2007, 27:796-816.
64. Prieto P. In vitro and clinical experiences with a human milk oligosaccharide, lacto-N-neotetraose, and fructooligosaccharides. Foods and Food Ingredients Journal Japan 2005, 210:1018-1030.
65. Reddy M.S., Bernstein J.M., Murphy T.F., Faden H.S. Binding between outer membrane proteins of nontypeable Haemophilus influenzae and human nasopharyngeal mucin. Infection and Immunity 1996, 64:1477-1479.
66. Roberts D.D., Olson L.D., Barile M.F., Ginsburg V., Krivan H.C. Sialic acid-dependent adhesion of Mycoplasma pneumoniae to purified glycoproteins. Journal of Biological Chemistry 1989, 264:9289-9293.
67. Ruvoën-Clouet N., Mas E., Marionneau S., Guillon P., Lombardo D., Le Pendu J. Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochemical Journal 2006, 393:627-634.
68. Sampathkumar S.G., Li A., Yarema K.J. Sialic acid and the central nervous system: perspectives on biological functions, detection, imaging methods and manipulation. CNS and Neurological Disorders - Drug Targets 2006, 5:425-440.
69. Scharfman A., Arora S.K., Delmotte P., Van Brussel E., Mazurier J., Ramphal R., et al. Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infection and Immunity 2001, 69:5243-5248.
70. Scharfman A., Degroote S., Beau J., Lamblin G., Roussel P., Mazurier J. Pseudomonas aeruginosa binds to neoglycoconjugates bearing mucin carbohydrate determinants and predominantly to sialyl-Lewis x conjugates. Glycobiology 1999, 9:757-764.
71. Shoaf K., Mulvey G.L., Armstrong G.D., Hutkins R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infection and Immunity 2006, 74:6920-6928.
72. Sinclair H.R., de Slegte J., Gibson G.R., Rastall R.A. Galactooligosaccharides (GOS) inhibit Vibrio cholerae toxin binding to its GM1 receptor. Journal of Agricultural and Food Chemistry 2009, 57:3113-3119.
73. St Geme J.W. The HMW1 adhesin of nontypeable Haemophilus influenzae recognizes sialylated glycoprotein receptors on cultured human epithelial cells. Infection and Immunity 1994, 62:3881-3889.
74. Stepans M.B., Wilhelm S.L., Hertzog M., Rodehorst T.K., Blaney S., Clemens B., et al. Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. Breastfeeding Medicine 2006, 1:207-215.
75. Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biological and Pharmaceutical Bulletin 2005, 28:399-408.
76. Tan M., Jiang X. Norovirus-host interaction: implications for disease control and prevention. Expert Reviews in Molecular Medicine 2007, 9:1-22.
77. Tao N., DePeters E.J., German J.B., Grimm R., Lebrilla C.B. Bottom of form variations in bovine milk oligosaccharides during early and middle lactation stages analyzed by high-performance liquid chromatography-chip/mass spectrometry. Journal of Dairy Science 2009, 92:2991-3001.
78. Thomas R., Brooks T. Common oligosaccharide moieties inhibit the adherence of typical and atypical respiratory pathogens. Journal of Medical Microbiology 2004, 53:833-840.
79. Wang X., Hirmo S., Willen R., Wadstrom T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model. Journal of Medical Microbiology 2001, 50:430-435.
80. Wang B., Yu B., Karim M., Hu H., Sun Y., McGreevy P., et al. Dietary sialic acid supplementation improves learning and memory in piglets. American Journal of Clinical Nutrition 2007, 85:561-569.